Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Prices
Pharma
Novo Nordisk attracts lawmakers' ire for Levemir insulin pull
Novo Nordisk is facing lawmaker pushback on its decision to discontinue its insulin product Levemir, which was due for a steep discount in January.
Fraiser Kansteiner
Apr 18, 2024 10:40am
DOJ sues Regeneron for under-reporting Eylea price to Medicare
Apr 11, 2024 11:12am
HHS responds to Big Pharma's IRA counteroffers
Apr 3, 2024 11:18am
GLP-1s still unavailable in lower-income countries: MSF
Mar 28, 2024 8:00am
In lawsuit, Amgen slams Colorado's proposed Enbrel price cap
Mar 26, 2024 12:30pm
Kyowa's Orchard hopes $4.25M gene therapy price tag bears fruit
Mar 20, 2024 10:40am